Literature DB >> 25812040

Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.

Deepti Bajpai1, Ayan Banerjee, Sujata Pathak, Bhaskar Thakur, Sunesh K Jain, Neeta Singh.   

Abstract

Genetic variation in DNA repair genes can modulate DNA repair capacity and may be related to the risk of cancer. The human papillomavirus is considered to be a necessary but not sufficient cause for cervical cancer and, therefore, other factors contribute to the carcinogenesis. A hereditary component for this neoplasia has been reported. Evaluation of the association of six polymorphisms was carried out in the following DNA repair genes: XRCC1 (Arg194Trp, Arg280His, and Arg399Gln), ERCC1 (Asp118Asp), ERCC2 (Lys751Gln), and ERCC4 (Arg415Gln). The cases (n=110) included 65 squamous cell carcinomas (SCCs) and 45 squamous intraepithelial lesions (SIL). Controls (n=68) were recruited from among women without cervical abnormalities. Genotypes were determined by PCR-restriction fragment length polymorphism and DNA sequencing. A positive association was observed between the polymorphisms of XRCC1 genes, that is, in codons 194 [P=0.001, odds ratio (OR)=20.1, 95% confidence interval (CI)=5.9-68.8], 280 (P=0.001, OR=5.4, 95% CI=2.3-12.6), and 399 (P=0.008, OR=4.2, 95% CI=1.5-12.1) and cervical cancer. SIL patients also showed a significant association with codon 194 (P=0.012, OR=3.8, 95% CI=1.3-10.6), but not with 280 (P=0.35) and 399 (P=0.81). A positive correlation was also found in ERCC4 Gln415Gln in both SCCs and SILs (P=0.001, OR=21.3, 95% CI=7.1-64.0 and P=0.001, OR=7.8, 95% CI=2.9-20.9, respectively). For ERCC2 Gln751Gln, the association was significant for both SCCs (P=0.001, OR=10.1, 95% CI=2.6-37.9) and SILs (P=0.001, OR=8.9, 95% CI=2.8-28.3). However, the risk of SCC did not appear to differ significantly among individuals with the ERCC1 Asp118Asp genotype (P=0.404). For SILs, it appeared to be a protective genotype (95% CI=0.1-0.7). This study indicates that variant types of DNA repair genes play an important role in modifying individual susceptibility to SCC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25812040     DOI: 10.1097/CEJ.0000000000000159

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  14 in total

1.  Association between interluekin-17 gene polymorphisms and the risk of cervical cancer in a Chinese population.

Authors:  Jianglin Cong; Riming Liu; Xuan Wang; Li Sheng; Haiyang Jiang; Weihua Wang; Youzhong Zhang; Shujuan Yang; Chaoying Li
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Elucidation of Increased Cervical Cancer Risk Due to Polymorphisms in XRCC1 (R399Q and R194W), ERCC5 (D1104H), and NQO1 (P187S).

Authors:  Shrishty Tyagi; Nisha Chaudhary; Agneesh Pratim Das; Sandeep Saini; Subhash Mohan Agarwal
Journal:  Reprod Sci       Date:  2022-10-04       Impact factor: 2.924

3.  Genetic Variant Arg399Gln G>A of XRCC1 DNA Repair Gene Enhanced Cancer Risk Among Indian Population: Evidence from Meta-analysis and Trial Sequence Analyses.

Authors:  Raju K Mandal; Rama D Mittal
Journal:  Indian J Clin Biochem       Date:  2017-07-10

4.  Genetic Variant XRCC1 rs1799782 (C194T) and Risk of Cancer Susceptibility in Indian Population: A Meta-analysis of Case-Control Studies.

Authors:  Raju Kumar Mandal; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2020-03-02

5.  DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.

Authors:  Patrizia Vici; Simonetta Buglioni; Domenico Sergi; Laura Pizzuti; Luigi Di Lauro; Barbara Antoniani; Francesca Sperati; Irene Terrenato; Mariantonia Carosi; Teresa Gamucci; Rosanna Dattilo; Monica Bartucci; Cristina Vincenzoni; Luciano Mariani; Enrico Vizza; Giuseppe Sanguineti; Angiolo Gadducci; Ilio Vitale; Maddalena Barba; Ruggero De Maria; Marcella Mottolese; Marcello Maugeri-Saccà
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

6.  Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancer.

Authors:  Na-Na Yang; Ying-Fan Huang; Jian Sun; Ying Chen; Zhong-Min Tang; Jin-Fang Jiang
Journal:  Oncotarget       Date:  2017-04-25

7.  Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.

Authors:  Xianling Zeng; Yafei Zhang; Ting Yue; Taohong Zhang; Junxia Wang; Yan Xue; Ruifang An
Journal:  Oncotarget       Date:  2017-01-10

Review 8.  Meta-Analysis of Polymorphic Variants Conferring Genetic Risk to Cervical Cancer in Indian Women Supports CYP1A1zzm321990as an Important Associated Locus

Authors:  Debmalya Sengupta; Udayan Guha; Sagnik Mitra; Sampurna Ghosh; Samsiddhi Bhattacharjee; Mainak Sengupta
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

9.  Significance of miR-141 and miR-340 in cervical squamous cell carcinoma.

Authors:  Wenting Li; Bo Yang; Yiqun Li; Cuicui Wang; Xinzhi Fang
Journal:  Open Med (Wars)       Date:  2021-06-16

Review 10.  The Pivotal Role of DNA Repair in Infection Mediated-Inflammation and Cancer.

Authors:  Ayse Z Sahan; Tapas K Hazra; Soumita Das
Journal:  Front Microbiol       Date:  2018-04-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.